MedTrace Logo

Ceftriaxone in Non-neutropenic Fever

NCT01225718 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 463

Last updated 2017-04-17

No results posted yet for this study

Summary

This is a retrospective chart review of all patients cared for at Monroe Carell Jr. Children's Hospital at Vanderbilt including the following:

* patients between 2007-2009 with malignancy, Langerhans cell histiocytosis (LCH) or hemophagocytic lymphohistiocytosis (HLH) and a central venous catheter who were under 23 years of age at time of diagnosis in order to ascertain the associated symptoms, management and outcome of all episodes of non-neutropenic fever.
* to identify a subset of low-risk patients that can be safely managed without use of empiric antibiotics.

Conditions

  • Histiocytosis
  • Pediatric Patients With Cancer

Sponsors & Collaborators

  • Vanderbilt University Medical Center

    lead OTHER

Eligibility

Max Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2016-06-25
Completion
2016-06-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01225718 on ClinicalTrials.gov